The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of ARomatase inhibitors AssessmenT in daily practice through educational approach (CARIATIDE) study

Adherence to medication.

Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974 · see citing works

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thurlimann, B. J. K., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,839 · see citing works

Interventions for enhancing medication adherence

Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945 · see citing works

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Aebi, S. P., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,849 · see citing works

The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication

Horne, R., Weinman, J. A., & Hankins, M. C. (1999) · Psychology and Health · doi:10.1080/08870449908407311 · Cited by 2,383 · see citing works

Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness

Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00057-4 · Cited by 2,201 · see citing works

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674 · see citing works

Interventions for enhancing medication adherence

Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244 · see citing works

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

Williams, N. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70385-6 · Cited by 918 · see citing works

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870 · see citing works

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. A., Giordano, S. H., Hudis, C. A., Malin, J. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 794 · see citing works

Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Mouridsen, H. T., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jaenicke, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.194 · Cited by 741 · see citing works

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676 · see citing works

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

Partridge, A. H., LaFountain, A., Mayer, E. L., Taylor, B. S., Winer, E. P., & Asnis-Alibozek, A. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 483 · see citing works

Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the Necessity–Concerns Framework

Clifford, S., Barber, N., & Horne, R. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.05.004 · Cited by 384 · see citing works

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.

Waterhouse, D. M., Calzone, K. A., Mele, C., & Brenner, D. E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1189 · Cited by 313 · see citing works

Intentional and non-intentional non-adherence to medication amongst breast cancer patients

Atkins, L., & Fallowfield, L. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.03.004 · Cited by 300 · see citing works

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Aebi, S. P., Davidson, T., Gruber, G., & Cardoso, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr371 · Cited by 255 · see citing works

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial

Cuzick, J. M., Šestak, I., Cella, D. F., & Fallowfield, L. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70259-6 · Cited by 186 · see citing works

Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer

Sedjo, R. L., & Devine, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0952-6 · Cited by 169 · see citing works

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

Hadji, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.02.001 · Cited by 133 · see citing works

Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time

Cluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D., Berenger, C., Carrieri, M. P., & Giorgi, R. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr330 · Cited by 133 · see citing works

The patient’s anastrozole compliance to therapy (PACT) program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer

Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Lück, H.-J., Windemuth-Kieselbach, C., Zaun, S., & Kreienberg, R. (2013) · Annals of Oncology · doi:10.1093/annonc/mds653 · Cited by 122 · see citing works

Aromatase inhibitor-induced arthralgia: Clinical experience and treatment recommendations

Coleman, R. E., Bolten, W. W., Lansdown, M., Dale, S., Jackisch, C., Merkel, D. E., Maass, N., & Hadji, P. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.10.004 · Cited by 122 · see citing works

Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients

Ma, A. M. T., Barone, J., Wallis, A. E., Wu, N. J., Garcia, L. B., Estabrook, A., Rosenbaum-Smith, S. M., & Tartter, P. I. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.06.027 · Cited by 115 · see citing works

Discrepancy in patient and physician perception of patient’s quality of life related to urinary symptoms

Rodríguez, L. V., Blander, D. S., Dorey, F. J., Raz, S., & Zimmern, P. E. (2003) · Urology · doi:10.1016/s0090-4295(03)00144-4 · Cited by 108 · see citing works

Insight into Barriers Against Optimal Adherence to Oral Hormonal Therapy in Women with Breast Cancer

Kirk, M. C., & Hudis, C. A. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.016 · Cited by 87 · see citing works

Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review

Banning, M. (2011) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2011.01295.x · Cited by 83 · see citing works

Follow-up Cost of Breast Cancer Patients with Localized Disease After Primary Treatment: a Randomized Trial

Kokko, R., Hakama, M., & Holli, K. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-5199-2 · Cited by 74 · see citing works

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy

Hadji, P., Jackisch, C., Bolten, W. W., Blettner, M., Hindenburg, H., Klein, P., König, K., Kreienberg, R., Rief, W., Wallwiener, D. R., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt513 · Cited by 69 · see citing works

Patients' knowledge and experience of adjuvant endocrine therapy for early breast cancer: a European study.

Wengström, Y., Aapro, M., di Priolo, S. L., Cannon, H., & Georgiou, V. (2007) · Breast · doi:10.1016/j.breast.2007.02.007 · Cited by 54 · see citing works

A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer

Yu, K.-D., Zhou, Y., Liu, G.-Y., Li, B., He, P.-Q., Zhang, H.-W., Lou, L.-H., Wang, X.-J., Wang, S., Tang, J.-H., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2059-8 · Cited by 50 · see citing works

High non-compliance in the use of letrozole after 2.5years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial

Fontein, D. B. Y., Nortier, J. W. R., Liefers, G., Putter, H., Kranenbarg, E. M., Bosch, J., Maartense, E., Rutgers, E. J. T., & van de Velde, C. J. H. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.11.010 · Cited by 50 · see citing works

Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.

Davidson, B., Vogel, V. G., & Wickerham, D. L. (2007) · PubMed · Cited by 42 · see citing works

Assessment of Migraine Severity Using the Migsev Scale: Relationship to Migraine Features and Quality of Life

Hasnaoui, A. E., Vray, M., Blin, P., et al. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00660.x · Cited by 36 · see citing works

The Attitudes, Communication, Treatment, and Support Intervention to Reduce Breast Cancer Treatment Disparity

Rosenzweig, M. Q., Brufsky, A., Rastogi, P., Puhalla, S., Simon, J., & Underwood, S. M. (2010) · Oncology nursing forum · doi:10.1188/11.onf.85-89 · Cited by 35 · see citing works

Existing treatment strategies: does noncompliance make a difference?

Caro, J. J., & Speckman, J. L. (1998) · PubMed · Cited by 34 · see citing works

Duration of adjuvant endocrine therapy of breast cancer: how much is enough?

Ward, J. H. (2009) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328334ff40 · Cited by 15 · see citing works

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations

Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397 · see citing works

Computerized versus hand-scored health literacy tools: a comparison of Simple Measure of Gobbledygook (SMOG) and Flesch-Kincaid in printed patient education materials

Leonard Grabeel, K., Russomanno, J., Oelschlegel, S., Tester, E., & Heidel, R. E. (2018) · Journal of the Medical Library Association · doi:10.5195/jmla.2018.262 · Cited by 96 · see citing works

Behavioral interventions to enhance adherence to hormone therapy in breast cancer survivors: a systematic literature review

Hurtado-de-Mendoza, A., Cabling, M. L., Lobo, T., Dash, C., & Sheppard, V. B. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.03.006 · Cited by 79 · see citing works

Interventions to promote adherence to endocrine therapy among breast cancer survivors: a meta-analysis

Finitsis, D. J., Vose, B. A., Mahalak, J. G., & Salner, A. L. (2019) · Psycho-Oncology · doi:10.1002/pon.4959 · Cited by 68 · see citing works

A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors

Bright, E. E., Finkelstein, L. B., Nealis, M. S., Genung, S. R., Wrigley, J., Gu, H. C. J., Schmiege, S. J., & Arch, J. J. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00697 · Cited by 74 · see citing works

A systematic review of interventions to improve adherence to endocrine therapy

Heiney, S. P., Parker, P. D., Felder, T. M., Adams, S. A., Omofuma, O. O., & Hulett, J. M. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5012-7 · Cited by 69 · see citing works

Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture

Badawy, S. Z. A., Brown, S. J., Kaufman, L., & Wojtowycz, M. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.01.009 · Cited by 12 · see citing works

Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole

de Jong, P. C., van de Ven, J., Nortier, J. W. R., Maitimu-Smeele, I., Denker, G. H., Thijssen, J. H. H., Slee, P. H. T. J., & Blankenstein, M. A. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)84407-3 · Cited by 47 · see citing works

Development and Evaluation of Clinical Application of Aromatase Inhibitors for Palliative Treatment Patients with Breast Cancer

Shige, Z. (2005) · Zhongguo yiyuan yongyao pingjia yu fenxi

A letrozole-based dual aromatase–sulphatase inhibitor with in vivo activity

Wood, P. M., Woo, L. W. L., Humphreys, A., Chander, S. K., Purohit, A., Reed, M. J., & Potter, B. V. L. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.028 · Cited by 41 · see citing works

Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer.

Nakamura, J., Imai, E., Yoshihama, M., et al. (1998) · PubMed · Cited by 9 · see citing works